Ruptured triple hormone-secreting adrenal cortical carcinoma with hyperaldosteronism, hypercortisolism, and elevated normetanephrine: a case report
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We report a case of a ruptured triple hormone-secreting adrenal mass with hyperaldosteronism, hypercortisolism, and elevated normetanephrine levels, diagnosed as adrenal cortical carcinoma (ACC) by histology. A 53-year-old male patient who initially presented with abdominal pain was referred to our hospital for angiocoagulation of an adrenal mass rupture. Abdominal computed tomography revealed a heterogeneous 19×11×15 cm right adrenal mass with invasion into the right lobe of the liver, inferior vena cava, retrocaval lymph nodes, and aortocaval lymph nodes. Angiocoagulation was performed. Laboratory evaluation revealed excess cortisol via a positive 1-mg overnight dexamethasone suppression test, primary hyperaldosteronism via a positive saline infusion test, and plasma normetanephrine levels three times higher than normal. An adrenal mass biopsy was performed for pathological confirmation to commence palliative chemotherapy because surgical management was not deemed appropriate considering the extent of the tumor. Pathological examination revealed stage T4N1M1 ACC. The patient started the first cycle of adjuvant mitotane therapy along with adjuvant treatment with doxorubicin, cisplatin, and etoposide, and was discharged. Clinical cases of dual cortisol- and aldosterone-secreting ACCs or ACCs presenting as pheochromocytomas have occasionally been reported; however, both are rare. Moreover, to the best of our knowledge, a triple hormone-secreting ACC has not yet been reported. Here, we report a rare case and its management. This case report underscores the necessity of performing comprehensive clinical and biochemical hormone evaluations in patients with adrenal masses because ACC can present with multiple hormone elevations.
Abstract
We report a case of a ruptured triple hormone-secreting adrenal mass with hyperaldosteronism, hypercortisolism, and elevated normetanephrine levels, diagnosed as adrenal cortical carcinoma (ACC) by histology. A 53-year-old male patient who initially presented with abdominal pain was referred to our hospital for angiocoagulation of an adrenal mass rupture. Abdominal computed tomography revealed a heterogeneous 19×11×15 cm right adrenal mass with invasion into the right lobe of the liver, inferior vena cava, retrocaval lymph nodes, and aortocaval lymph nodes. Angiocoagulation was performed. Laboratory evaluation revealed excess cortisol via a positive 1-mg overnight dexamethasone suppression test, primary hyperaldosteronism via a positive saline infusion test, and plasma normetanephrine levels three times higher than normal. An adrenal mass biopsy was performed for pathological confirmation to commence palliative chemotherapy because surgical management was not deemed appropriate considering the extent of the tumor. Pathological examination revealed stage T4N1M1 ACC. The patient started the first cycle of adjuvant mitotane therapy along with adjuvant treatment with doxorubicin, cisplatin, and etoposide, and was discharged. Clinical cases of dual cortisol- and aldosterone-secreting ACCs or ACCs presenting as pheochromocytomas have occasionally been reported; however, both are rare. Moreover, to the best of our knowledge, a triple hormone-secreting ACC has not yet been reported. Here, we report a rare case and its management. This case report underscores the necessity of performing comprehensive clinical and biochemical hormone evaluations in patients with adrenal masses because ACC can present with multiple hormone elevations.
참고문헌 (20)
- Fassnacht M, "Update in adrenocortical carcinoma", J Clin Endocrinol Metab, 98, pp.4551~4564 (2013)
- Sharma E, "The characteristics and trends in adrenocortical carcinoma : a United States population based study", J Clin Med Res, 10, pp.636~640 (2018)
- Lerario AM, "Update on biology and genomics of adrenocortical carcinomas : rationale for emerging therapies", Endocr Rev, 43, pp.1051~1073 (2022)
- Bancos I, "Approach to the patient with adrenal incidentaloma", J Clin Endocrinol Metab, 106, pp.3331~3353 (2021)
- Mansmann G, "The clinically inapparent adrenal mass : update in diagnosis and management", Endocr Rev, 25, pp.309~340 (2004)
- Else T, "Adrenocortical carcinoma", Endocr Rev, 35, pp.282~326 (2014)
- Zern NK, "Aldosterone-secreting adrenocortical carcinoma presenting with cardiac arrest", J Endocr Soc, 3, pp.1678~1681 (2019)
- Griffin AC, "Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature", Endocr Pathol, 25, pp.344~349 (2014)
- Libè R, "Adrenocortical cancer : pathophysiology and clinical management", Endocr Relat Cancer, 14, pp.13~28 (2007)
- "Coincidence of pheochromocytoma and adrenocortical carcinoma at the same adrenal gland in a patient with neurofibromatosis" (2004)[URL]
- Fassnacht M, "European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors", Eur J Endocrinol, 179, pp.G1~G46 (2018)
- Allolio B, "Clinical review: adrenocortical carcinoma. Clinical update", J Clin Endocrinol Metab, 91, pp.2027~2037 (2006)
- Sada A, "Comparison between functional and non-functional adrenocortical carcinoma", Surgery, 167, pp.216~223 (2020)
- Rosenberg R, "Dual aldosterone-and cortisol-secreting adrenal cortical carcinoma : pre-and perioperative evaluation and management", JCEM Case Rep, 1, pp.luad073~ (2023)
- Funder JW, "Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline", J Clin Endocrinol Metab, 93, pp.3266~3281 (2008)
- Fassnacht M, "European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors", Eur J Endocrinol, 189, pp.G1~G42 (2023)
- González LAR, "Metanephrine-producing adrenocortical carcinoma : a case report", Rev Latinoam Hipertens, 16, pp.173~175 (2021)
- Bagchi PK, "Giant adrenal tumor presenting as Cushing's syndrome and pheochromocytoma : a case report", Asian J Urol, 2, pp.182~184 (2015)
- Ni H, "Adrenal cortical carcinoma masquerading as pheochromocytoma : a case report", Ecancermedicalscience, 6, pp.277~ (2012)
- Alsabek MB, "Mixed corticomedullary adrenal carcinoma: case report. Comparison in features, treatment and prognosis with the other two reported cases", Int J Surg Case Rep, 31, pp.254~261 (2017)